Shares of Amarin (AMRN -4.4%) spike lower after the FDA's latest Orange Book update shows no...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Shares of Amarin (AMRN -4.4%) spike lower after the FDA's latest Orange Book update shows no change in the status of its fish-oil pill Vascepa. M&A speculators had been optimistic on a decision from regulators over the exclusivity of the pill would be coming this month, because last week a draft response letter made the rounds around the FDA which made no mention of 'no decision' this month, as it has previously before.